Total Clarity Wealth Management, Inc. Curis Inc Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$4.45 - $8.09 $28,431 - $51,687	-6,389 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$6.94 - $8.85 $44,339 - $56,542	6,389 New	6,389 $50,000
Q2 2021 Jul 26, 2021	SELL	$7.45 - $16.27 $32,891 - $71,832	-4,415 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$8.78 - $12.8 $38,763 - $56,512	4,415 New	4,415 $50,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.